Can a smartphone app help reverse type 2 diabetes?

NCT ID NCT07361640

First seen Jan 26, 2026

Summary

This pilot study is testing a Norwegian e-health program called DiaMester for adults with type 2 diabetes. The program includes digital education, coaching, and a low-calorie diet to help participants lose weight and potentially achieve diabetes remission. About 99 people will take part, and the main goal is to see how much weight they lose over the study period.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Oslo University Hospital

    RECRUITING

    Oslo, 0424, Norway

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

    Contact

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

    Contact

    Contact

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

e-health lifestyle program (digital education, coaching, and diet replacement)

What this could lead to

If successful, this program could offer a scalable digital tool to help people with type 2 diabetes achieve significant weight loss and possibly remission without needing lifelong medication.

What could go wrong

This is a small pilot study, so results may not be generalizable. Weight loss and remission are challenging to maintain long-term, and the program requires high participant commitment.

Conditions

The condition(s) this trial relates to.

diabetes mellitus Feeding and Eating Disorders type 2 diabetes mellitus Weight Loss

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.